Research suggests that glutathione is the primary defender against this process
If you have MTHFR or a genetic glutathione recycling deficiency this presents a challenge in keeping our antioxidant levels peaked
Additionally, real-world data suggest a broader neuroprotective potential, as GLP-1 RAs like semaglutide have been linked to reduced dementia risk in patients with T2D [60]
Age, overall health, lifestyle, and previous peptide therapy experience all influence the ideal candidates
Zhong, J., Rao, X., and Rajagopalan, S
GLP-1 injections are, of course, a remarkable tool for anybody with diabetes, insulin resistance, or metabolic disease